GOWRI PADMA THUMMALA: Open Payments
NPI 1831622612 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 63 payments from 15 companies in 2025. Trend: 2023 $35 · 2024 $545 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $264 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $188 |
| Otsuka America Pharmaceutical, Inc. | 10 | $183 |
| Axsome Therapeutics, Inc. | 7 | $137 |
| Janssen Pharmaceuticals, Inc | 5 | $129 |
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| ABBVIE INC. | 4 | $72 |
| Lundbeck LLC | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
Products named: INGREZZA, REXULTI, CAPLYTA, Auvelity, SPRAVATO, AUSTEDO XR, VRAYLAR, FANAPT.
Industry payments across GA — which companies pay providers there.
